Global Oncology Partnering Directory 2020 - Access to Over 4,000 Oncology Deal Records
05 févr. 2021 08h28 HE
|
Research and Markets
Dublin, Feb. 05, 2021 (GLOBE NEWSWIRE) -- The "Global Oncology Partnering 2015-2020: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. The Global...
Outlook on the Blood Cancer Drugs Global Market to 2026 - by Product, Treatment Approach, Application and Region
18 janv. 2021 05h13 HE
|
Research and Markets
Dublin, Jan. 18, 2021 (GLOBE NEWSWIRE) -- The "Blood Cancer Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's...
Graft Versus Host Disease (GVHD) Pipeline Review 2020: Therapeutics Development, Therapeutics Assessment and Companies Involved in Therapeutics Development
27 oct. 2020 05h03 HE
|
Research and Markets
Dublin, Oct. 27, 2020 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. This report provides...
Global PD-1/PD-L1 Immunotherapy Market Analysis and Forecast, 2019-2020 & 2030
23 oct. 2020 04h53 HE
|
Research and Markets
Dublin, Oct. 23, 2020 (GLOBE NEWSWIRE) -- The "Global PD-1/PD-L1 Immunotherapy Market: Focus on Type, Application, Country Data (14 Countries), and Competitive Landscape - Analysis and Forecast,...
Hemispherx Biopharma's Ampligen(R) Cited at Barcelona Vaccine & Active Immunotherapeutics Forum 2011
12 mai 2011 13h00 HE
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, May 12, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") today announced that Ampligen® will be featured in a discussion of...